Top Markets
Coin of the day
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA
Classement en actions #32451
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on... Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
Prix de l'action
$1.11
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$10.06M
Changement (1 jour)
1.38%
Changement (1 an)
-55.98%
Pays
US
Échange Lisata Therapeutics, Inc. (LSTA)

Catégorie

Historique des divisions d’actions pour Lisata Therapeutics, Inc. (LSTA)
L’action Lisata Therapeutics, Inc. (symbole : LSTA) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 18, 2026.
Une action LSTA achetée avant le Aug 18, 2026 équivaudrait aujourd’hui à 0 actions LSTA.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE